Scientific article
OA Policy
English

In vivo absolute quantification of striatal and extrastriatal D2/3 receptors with [123I]epidepride SPECT

Published in

EJNMMI Research, vol. 10, no. 1, 66

Publication date

2020

Abstract

[123I]epidepride is a high-affinity radiotracer used in single-photon emission computed tomography(SPECT) imaging of the D2/3receptors. It binds with high affinity to striatal and extrastriatal receptors. Nevertheless,its slow kinetics in the striatum impedes quantification in this region. Thus, an approach that would allow a simultaneousquantification of both striatal and extrastriatal D2/3receptors would be of interest for preclinical and clinical SPECTneuroimaging. We describe a partial saturation protocol that allows us to produce an in vivo Scatchard plot and thusestimate Bavailand appKdseparately in both striatal and extrastriatal regions, through a single dynamic SPECT session. Tovalidate this approach, a multi-injection protocol is used for the full kinetic modeling of [123I]epidepride using a two-tissuecompartment, 5-parameter model (2T-5k).

Keywords

  • [123I]epidepride
  • D2/3receptor
  • Dopamine
  • Molecular imaging
  • SPECT
  • Rat

Citation (ISO format)

TSARTSALIS, Stergios, TOURNIER, Benjamin, MILLET, Philippe. In vivo absolute quantification of striatal and extrastriatal D2/3 receptors with [123I]epidepride SPECT. In: EJNMMI Research, 2020, vol. 10, n° 1, p. 66. doi: 10.1186/s13550-020-00650-0

Main files (1)

Article (Published version)

Secondary files (1)

Supplemental data

Identifiers

Journal ISSN

2191-219X
360views
168downloads

Technical informations

Creation

16/06/2020 22:14:00

First validation

16/06/2020 22:14:00

Update

13/10/2025 17:18:31

Status update

17/01/2025 16:32:01

Last indexation

03/11/2025 16:25:44
All rights reserved by Archive ouverte UNIGE and the University of Geneva
OpenAIRE Indexed & Validated